Grifols (GIKLY) Long-Term Investments (2010 - 2025)

Grifols (GIKLY) reported Long-Term Investments of $112.9 million for Q4 2025, up 53.14% on a YoY basis from $73.7 million in Q4 2024, and up 53.14% quarter-over-quarter from $73.7 million in Q4 2024.

Grifols (GIKLY) Long-Term Investments (2010 - 2025) Analysis & Trends

Grifols has reported Long-Term Investments for 16 years, with the latest figure at $112.9 million in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments rose 53.14% year-over-year to $112.9 million; the trailing twelve-month figure through Dec 2025 stood at $112.9 million (up 53.14% YoY), and the FY2025 full-year result was $112.9 million, up 1781.87% from the prior year.
  • Long-Term Investments for Q4 2025 stood at $112.9 million, up from $73.7 million in the prior quarter.
  • The five-year high for Long-Term Investments was $1.8 billion in Q4 2021, with the low at $73.7 million in Q4 2024.
  • Historically, Long-Term Investments has averaged $786.5 million across 5 years, with a median of $453.0 million in 2023.
  • Annual changes were most pronounced in 2021 — Long-Term Investments soared 423.86% — and 2024, when it tumbled 83.72%.
  • Grifols' Long-Term Investments stood at $1.8 billion in 2021, then retreated by 13.39% to $1.5 billion in 2022, then slumped by 70.36% to $453.0 million in 2023, then plunged by 83.72% to $73.7 million in 2024, then soared by 53.14% to $112.9 million in 2025.
  • The last three Long-Term Investments figures came in at $112.9 million (Q4 2025), $73.7 million (Q4 2024), and $453.0 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 133.47 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 3.12 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 268.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 1.11 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 983.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 1.63 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 366.00 Mn
10 Grifols - - - 112.91 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 112.91 Mn
Dec 31, 2024 73.73 Mn
Dec 31, 2023 452.97 Mn
Dec 31, 2022 1.53 Bn
Dec 31, 2021 1.76 Bn
Dec 31, 2020 -544.88 Mn
Sep 30, 2020 194.29 Mn
Mar 31, 2020 504.50 Mn
Dec 31, 2019 126.71 Mn
Sep 30, 2019 156.09 Mn
Mar 31, 2019 147.46 Mn
Dec 31, 2018 258.99 Mn
Sep 30, 2018 15.48 Mn
Jun 30, 2018 269.46 Mn
Mar 31, 2018 134.15 Mn
Dec 31, 2017 257.87 Mn
Jun 30, 2017 245.73 Mn
Dec 31, 2016 4.05 Mn
Sep 30, 2016 100.76 Mn
Jun 30, 2016 98.35 Mn